SCHEMBL20176726

SCHEMBL20176726

CCCCCC(CC)Cc1ccc(-c2ccc(-c3c4nccnc4c(-c4ccc(-c5ccc(CC(CC)CCCCC)cc5F)s4)c4nsnc34)s2)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18217165 0.89 — —
SCHEMBL20176732 0.87 — —
SCHEMBL18217130 0.87 ESR1 (0.30) —
SCHEMBL21594572 0.86 ESR1 (0.32) —
SCHEMBL18217186 0.86 CRHR1 (0.30) —
SCHEMBL21241719 0.86 SMN1; SMN2 (0.30) —
SCHEMBL20176729 0.85 RARB (0.35) —
SCHEMBL21019971 0.85 — —
SCHEMBL18217194 0.84 — —
SCHEMBL18217189 0.84 BDKRB2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738240-B2 Thiadiazoloquinoxaline derivatives MERCK PATENT GMBH (DE) 2020-08-11 — — US disclosed
US-20180142153-A1 THIADIAZOLOQUINOXALINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-05-24 — — US disclosed
US-20180142153-A1 THIADIAZOLOQUINOXALINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-05-24 — — US disclosed
Send feedback